Clinical Trials Directory

Trials / Completed

CompletedNCT06368362

Cognitive Bias Modification for Interpretation Individuals With Chronic Musculoskeletal Pain

The Effectiveness and Mediators of Cognitive Bias Modification for Interpretation in the Reduction of Negative Emotional Response to Pain in Individuals With Chronic Musculoskeletal Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
University of Southampton · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign, rather than interpret it as being related to pain. The goal of this randomised controlled trial was to explore the feasibility and potential clinical benefits of CBM-I in people with chronic pain and also healthy, pain-free individuals.

Detailed description

This study investigated whether Cognitive Bias Modification for Interpretation (CBM-I) could reduce negative emotional response to pain and to pain-related images, and whether reductions in interpretation bias (IB) and fear of pain mediated this effect. Participants with chronic musculoskeletal pain (N = 41) were randomised to benign CBM-I or no CBM-I, and healthy participants (N = 41) were randomised to benign CBM-I or pain-related CBM-I. After CBM-I, the study assessed pain-related IB and fear of pain, as well as negative emotional response to exercise-induced pain and images of musculoskeletal pain.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBenign cognitive bias modification for interpretationBenign cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign rather than pain-related.
BEHAVIORALPain-related cognitive bias modification for interpretationPain-related cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as pain-related.

Timeline

Start date
2020-11-17
Primary completion
2021-05-01
Completion
2021-05-01
First posted
2024-04-16
Last updated
2024-04-16

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06368362. Inclusion in this directory is not an endorsement.